How Many Americans Could be Treated with new PCSK9 Inhibitors Hint It Won't be as Many as Critics Claim

WASHINGTON July 24 2015 PRNewswireUSNewswire Despite claims that tens of millions of Americans could be eligible for treatment with a new class of cholesterollowering medications called PCSK9 inhibitors the fact is these new medicines will not replace exi...